Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2004-05-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Gene Changes in Brain Tumor Formation and Growth
NCT00059020
Risk Factors for Adult-Onset Brain Tumors
NCT00592865
Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain Tumours
NCT05025969
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
NCT00897611
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mouth Swab, Toe Nail Clippings, Questionnaires
The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosed within 4 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DR. Kathleen Egan
UNKNOWN
Kentuckiana Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kentuckiana Cancer Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renato V. LaRocca, MD
Role: PRINCIPAL_INVESTIGATOR
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kentuckiana Cancer Institute
Louisville, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRBTC2003-01
Identifier Type: -
Identifier Source: secondary_id
mrbt1-03-132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.